Down-regulation of CD7 is a known common feature of CTCL [63], and, thus, supports our assumption of a malignant phenotype for the C5 and C10_CD4_TE cells. The gene discussed is CD7; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.